HTTP/2 200
server: GitHub.com
content-type: text/html; charset=utf-8
last-modified: Tue, 02 Dec 2025 00:38:17 GMT
access-control-allow-origin: *
etag: W/"692e34f9-278c"
expires: Mon, 29 Dec 2025 01:08:00 GMT
cache-control: max-age=600
content-encoding: gzip
x-proxy-cache: MISS
x-github-request-id: 98A7:2916CC:82A67C:92B0A3:6951D217
accept-ranges: bytes
age: 0
date: Mon, 29 Dec 2025 00:58:00 GMT
via: 1.1 varnish
x-served-by: cache-bom-vanm7210062-BOM
x-cache: MISS
x-cache-hits: 0
x-timer: S1766969880.123327,VS0,VE206
vary: Accept-Encoding
x-fastly-request-id: ab9a681a770d1c690a0b0f2d62e76e551153804d
content-length: 3479
Home · Asif Khan
Skip to main content
Asif KhanPostdoctoral Fellow, Harvard Medical School
Asif Khan
Machine Learning & AI for MedicinePostdoctoral Fellow · Harvard Medical School
I am a Postdoctoral Fellow at Harvard Medical School, working with Chris Sander. Before Harvard, I completed my PhD with Amos Storkey in the Bayesian and Neural Systems Group at the University of Edinburgh. My doctoral thesis was on the geometry for deep representation learning.
My research lies at the intersection of machine learning and biomedicine, addressing two critical challenges in cancer biology: early detection using longitudinal patient records and optimization of combination therapies through mechanistic models of drug response. Late-stage diagnosis remains the primary cause of cancer mortality, as many patients present when curative treatment is no longer possible. By training AI on large-scale clinical data, our work aims to identify high-risk individuals who can benefit from earlier intervention and effective treatment strategies. My current work is centered around following topics:
Representation learning from longitudinal EHRs: Developing foundation models that encode patient histories into continuous representation spaces of patient health states for downstream survival and risk assessments.
Uncertainty-aware cancer risk prediction: Building well-calibrated, robust, and generalizable models that capture distribution shifts across hospitals and populations.
AI-guided therapy design: Learning differential equation models that capture molecular dynamics under drug perturbations to inform combination therapies.
Interests
Representation learning
Geometry for deep learning
Computational biology
Cancer risk stratification
Education
PhD in Machine Learning, University of Edinburgh2018–2023
Bayesian and Neural Systems Group (Prof. Amos Storkey)
MSc in Computer Science, University of Bonn2016–2018
Representation learning from large-scale real-world EHR data
Transforming longitudinal patient trajectories into structured embeddings that capture the evolving health state of patients and support downstream clinical decision-making tasks.
Multi-cancer risk prediction
Developing well-calibrated deep learning event models that predict cancer risk across horizons while quantifying uncertainty at the patient level.
Machine learning models for combination therapy (Perturb • Measure • Model • Predict • Test)
Modeling cellular dynamics with machine-learning driven differential equation models trained on drug and CRISPR perturbation data.